Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-03-14 | Mr. Foletta is qualified to serve on the Board because he brings considerable audit and financial experience and has experience as a public company director. Mr. Foletta is also designated as a financial expert on the Audit Committee. |
| 2014-03-12 | Mr. Foletta received a B.A. from the University of California, Santa Barbara. He is a Certified Public Accountant (inactive) and a member of the Corporate Directors Forum. |
| 2015-03-11 | Mr. Foletta is qualified to serve on the Board because he brings considerable audit, financial and healthcare experience and also has experience as a public company director. Mr. Foletta is also designated as a financial expert on the Audit Committee. |
| 2016-03-10 | Mr. Foletta is qualified to serve on the Board because he brings considerable audit, financial and healthcare experience and also has experience as a public company director. |
| 2017-03-09 | Mr. Foletta is qualified to serve on the Board because he brings considerable audit, financial and healthcare experience and also has experience as a public company director. The Board has designated Mr. Foletta as a financial expert for its Audit Committee, for which he serves as Chairman. ... Mr. Foletta received a B.A. from the University of California, Santa Barbara. He is a Certified Public Accountant (inactive) and a member of the Corporate Directors Forum. |
| 2018-03-08 | The Board has concluded that Mr. Foletta is qualified to serve on the Board because he brings considerable audit, financial, healthcare and enterprise risk management experience as both an executive officer and director of healthcare companies. |
| 2019-03-07 | Executive Vice President and Chief Financial Officer, Tocagen Inc. ... The Board has concluded that Mr. Foletta is qualified to serve on the Board, because he brings considerable audit, financial, healthcare and enterprise risk management experience as both an executive officer and director of healthcare companies. |
| 2020-03-11 | Executive Vice President and Chief Financial Officer, Tocagen Inc. The Board has concluded that Mr. Foletta is qualified to serve on the Board, because he brings considerable audit, financial, healthcare and enterprise risk management experience as both an executive officer and director of healthcare companies. |
| 2021-03-10 | Former Executive Vice President and Chief Financial Officer, Tocagen Inc. ... Certified Public Accountant (inactive) and a member of the Corporate Directors Forum. |
| 2022-03-24 | Former Executive Vice President and Chief Financial Officer, Tocagen Inc.; serves on boards of healthcare and biotechnology companies. |
| 2023-04-04 | Executive Vice President and Chief Financial Officer of Tocagen Inc., a brain cancer biotechnology company; Interim CFO of Biocept, Inc.; Senior Vice President, Finance and CFO of Amylin Pharmaceuticals, Inc. |
| 2024-03-05 | Mr. Foletta brings to the Board considerable audit, financial, healthcare and enterprise risk management experience as both an executive officer and director of healthcare companies. Mr. Foletta’s prior experience as a public company CFO provides the Board with extensive public company accounting and financial reporting expertise. |
| 2025-03-18 | Mr. Foletta brings to the Board considerable audit, financial, healthcare and enterprise risk management experience as both an executive officer and director of healthcare companies and has significant experience serving the Company under different operating environments, management teams, and market cycles strengthening the Board’s perspective and capabilities. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-10 | Mr. Foletta received a B.A. in Business Economics from the University of California, Santa Barbara and is a member of the Corporate Directors Forum. Mr. Foletta’s considerable audit and financial experience in the biotechnology and pharmaceutical sectors qualifies him to serve on the Board. |
| 2021-04-09 | Mr. Foletta received a B.A. in Business Economics from the University of California, Santa Barbara and is a member of the Corporate Directors Forum. |
| 2022-04-08 | Mr. Foletta has considerable audit and financial experience in the biotechnology and pharmaceutical sectors. |
| 2023-04-06 | Mr. Foletta received a B.A. in Business Economics from the University of California, Santa Barbara and is a member of the Corporate Directors Forum. Mr. Foletta’s considerable audit and financial experience in the biotechnology and pharmaceutical sectors qualifies him to serve on the Board. |
| 2024-04-22 | Mr. Foletta received a B.A. in Business Economics from the University of California, Santa Barbara and is a member of the Corporate Directors Forum. |
| 2025-03-27 | Mr. Foletta received a B.A. in Business Economics from the University of California, Santa Barbara and is a member of the Corporate Directors Forum. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-01-21 | Mark G. Foletta was elected to our board of directors in June 2020. Mr. Foletta had been the Chief Financial Officer and Executive Vice President of Tocagen, Inc., ... Mr. Foletta received a B.A. in Business Economics from the University of California, Santa Barbara. |
| 2022-01-21 | Mr. Foletta received a B.A. in Business Economics from the University of California, Santa Barbara. We believe that Mr. Foletta’s considerable audit and financial experience in the biotechnology and healthcare sectors qualifies him to serve on our board of directors. |
| 2023-01-20 | Mr. Foletta received a B.A. in Business Economics from the University of California, Santa Barbara. We believe that Mr. Foletta's considerable audit and financial experience in the biotechnology and healthcare sectors qualifies him to serve on our board of directors. |
| 2024-01-26 | Mr. Foletta received a B.A. in Business Economics from the University of California, Santa Barbara. |
| 2025-01-27 | Mr. Foletta received a B.A. in Business Economics from the University of California, Santa Barbara. We believe that Mr. Foletta’s considerable audit and financial experience in the biotechnology and healthcare sectors qualifies him to serve on our Board of Directors. |
Data sourced from SEC filings. Last updated: 2026-02-03